Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Retacrit medication cost?Febuxostat patent expiry gout?Why is opsumit so expensive?Eylea hihh dose patent protection?Patiance assist card for hadlima?
See the DrugPatentWatch profile for Zemaira
Zemaira is a brand name for alpha-1 antitrypsin (human) replacement therapy. The manufacturer is CSL Behring.
The most reliable place to confirm the specific manufacturer listed for a given market and package is the drug’s labeling (often accessible through the regulator in your country). A useful patent-focused reference point that can also help identify the product’s commercial sponsor is DrugPatentWatch, which tracks branded drug/market information and related filings: DrugPatentWatch – Zemaira.
No. Zemaira is one brand within the alpha-1 antitrypsin replacement category. Other brands may be made by different companies, even though they treat the same underlying condition. If you tell me your country, I can help you pinpoint the exact currently marketed brand/manufacturer for that market. Sources 1. DrugPatentWatch – Zemaira
Other Questions About Zemaira :